Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and the maternal and neonatal outcomes, a multicenter retrospective cohort study
CONCLUSION: In a motivated population covered by a National Health Insurance Plan, we found a 40.2% rate of vaccination for the Covid-19 vaccine during the third trimester of pregnancy which was not associated with adverse maternal outcomes and decreased the risk for neonatal adverse outcomes.PMID:34554630 | DOI:10.1111/1471-0528.16941
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Misgav Rottenstreich Hen Y Sela Reut Rotem Ela Kadish Yonit Wiener-Well Sorina Grisaru-Granovsky Source Type: research
More News: Computers | COVID-19 | Databases & Libraries | Health Insurance | Insurance | OBGYN | Operative Vaginal Delivery | Perinatology & Neonatology | Pfizer | Pregnancy | Study | Vaccines | Women